Your Messages Inbox
Your Article Summary
See Latest ArticlesTreatment of Kawasaki Disease: Analysis of 27 US Pediatric Hospitals From 2001 to 2006
Pediatrics, 07/10/09
Son MBF et al. - This report provides the first large multicenter description of agents used in the treatment of intravenously administered immunoglobulin-resistant Kawasaki disease in the United States. Trends include increased numbers of admissions attributable to Kawasaki disease and increased usage of infliximab.
Related Articles
Six principal symptoms and coronary artery sequelae in Kawasaki disease
Pediatrics International, 10/07/09
Relevance Score: 69%
BTNL2 gene polymorphisms may be associated with susceptibility to Kawasaki disease and formation of coronary artery lesions in Taiwanese children
European Journal of Pediatrics, 11/05/09
Relevance Score: 67%
Rheumatic manifestations of Epstein-Barr virus in children
Journal of Pediatric Infectious Diseases, 11/02/09
Relevance Score: 67%
A unique plasma proteomic profiling with imbalanced fibrinogen cascade in patients with Kawasaki disease
Pediatric Allergy and Immunology, 10/26/09
Relevance Score: 66%
Transient unilateral oculomotor palsy and severe headache in childhood Kawasaki disease
Rheumatology International, 10/23/09
Relevance Score: 66%
Today in Physician/Patient Trends...keeping you current
Receive free subspecialty "5-minute updates" via email
Surgical and minimally invasive treatments for Peyronie's disease
Current Opinion in Urology, 11/19/09
Trends in prescribing and self-poisoning in relation to UK regulatory authority warnings against use of SSRI antidepressants in under-18-year-olds
British Journal of Clinical Pharmacology, 11/02/09
Derivation and Validation of the ASK-12 Adherence Barrier Survey
Annals of Pharmacotherapy, 10/15/09
Article Search
Sponsor